These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29082244)

  • 21. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
    Shen N; Huang X; Li J
    Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression.
    Li W; Ma H; Sun J
    Mol Med Rep; 2014 Apr; 9(4):1293-8. PubMed ID: 24482044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of miR-195 in laryngeal squamous cell carcinoma and its effect on proliferation and apoptosis of Hep-2.
    Shuang Y; Li C; Zhou X; Huang YW; Zhang L
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3232-3238. PubMed ID: 28770960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients.
    Garo Kyurkchiyan S; Miroslavov Popov T; Stancheva G; Rangachev J; Ivanov Mitev V; Petrova Popova D; Petrova Kaneva R
    J BUON; 2020; 25(1):357-366. PubMed ID: 32277655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of microRNA expression profiling in highly metastatic laryngocarcinoma cells.
    Chen L; Liu S; Li K; Qi J; Liu C; Zong L; Zhang Y; Zhao J; Zhai X; Li J; Kong X; Yang S; Liu M
    Acta Otolaryngol; 2018 Dec; 138(12):1105-1111. PubMed ID: 30702035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2.
    Zhao X; Zhang W; Ji W
    Biochem Biophys Res Commun; 2018 Jun; 501(2):584-592. PubMed ID: 29753737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
    Han L; Jiang B; Wu H; Zhang S; Lu X
    Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
    Tu XP; Li H; Chen LS; Luo XN; Lu ZM; Zhang SY; Chen SH
    BMC Cancer; 2020 Aug; 20(1):794. PubMed ID: 32838760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA CircSHKBP1 accelerates the proliferation, invasion, angiogenesis, and stem cell-like properties via modulation of microR-766-5p/high mobility group AT-hook 2 axis in laryngeal squamous cell carcinoma.
    Chen F; Zhang H; Wang J
    Bioengineered; 2022 May; 13(5):11551-11563. PubMed ID: 35502885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
    Wang JL; Wang X; Yang D; Shi WJ
    Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
    He FY; Liu HJ; Guo Q; Sheng JL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):760-764. PubMed ID: 28272707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.
    Ayaz L; Görür A; Yaroğlu HY; Ozcan C; Tamer L
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1499-506. PubMed ID: 23817697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1.
    Liu Y; Liu J; Wang L; Yang X; Liu X
    Mol Med Rep; 2017 Nov; 16(5):7154-7162. PubMed ID: 28901478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.